The Genesis Emerging Markets Trust believes in thorough fieldwork when seeking out promising investments.
The FTSE 100 saw a sharp rise yesterday after the Bank of England cut interest rates to 0.25% and extended its quantitative easing programme. The index closed up 1.6% at 6,740.
The board of the British medical devices company Smith & Nephew has parted ways with CEO Namal Nawana after only 18 months.
Not so long ago, investors were despondent, diving headfirst into “safe haven” bonds. Now, however, markets have perked up. John Stepek explains what’s going on.
Last week’s excitement over a Brexit deal getting done proved to be premature. John Stepek looks at where we are now, and what it means for your money.
Bill Gross – the billionaire co-founder of giant asset manager Pimco, is worried about the effect long-term low interest rates are having on the markets.
The small size of the region’s markets means that Eastern European stocks are often overlooked in favour of bigger Asian growth stories. Yet there is plenty of promise closer to home as well.
US stocks have eclipsed other markets over the past decade and continued to outperform this year. But that outperformance looks set to end.
Whatever wild turn the Brexit drama takes next, the important thing to remember is that UK stocks are trading at bargain-basement prices.
So we have a Brexit deal that both the EU and the government are happy with. It just needs to get past Parliament. John Stepek explains what’s likely to happen next, and what it all means for your money.
After botching its flotation, WeWork is facing a potentially fatal cash crunch. Digging itself out of this hole won’t come cheap. Matthew Partridge reports.
British cybersecurity company Sophos is a successful company with good prospects. So it’s no surprise that the American private-equity firm Thoma Bravo has offered £3.1bn for it.